Načítá se...
The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop preeclampsia
OBJECTIVE: To determine 1) whether maternal plasma concentrations of angiogenic and anti-angiogenic factors can predict which mothers diagnosed with “suspected small-for-gestational-age fetuses (sSGA)” will develop preeclampsia (PE) or require an indicated early preterm delivery (≤ 34 weeks of gesta...
Uloženo v:
| Vydáno v: | J Matern Fetal Neonatal Med |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5769689/ https://ncbi.nlm.nih.gov/pubmed/26303962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14767058.2015.1048431 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|